rozanolixizumab-noli 140 MG/ML
RxNorm concept 2642285, clinical drug component (scdc).
- RxCUI
- 2642285
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2642285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 2 ML rozanolixizumab-noli 140 MG/ML Injection (SCD, constitutes)
- 2 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo] (SBD, constitutes)
- 3 ML rozanolixizumab-noli 140 MG/ML Injection (SCD, constitutes)
- 3 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo] (SBD, constitutes)
- 4 ML rozanolixizumab-noli 140 MG/ML Injection (SCD, constitutes)
- 4 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo] (SBD, constitutes)
- 6 ML rozanolixizumab-noli 140 MG/ML Injection (SCD, constitutes)
- 6 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo] (SBD, constitutes)
- rozanolixizumab (IN, has ingredient)
- rozanolixizumab-noli (PIN, has precise ingredient)
- rozanolixizumab-noli 140 MG/ML [Rystiggo] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2642285 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2642285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2642285. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.